| Variable | n =35 |
|---|---|
| Sex | |
| Male | 1 (2,9%) |
| Female | 34 (97,1%) |
| Age (years) | |
| (mean, SD) | 45,29 (±13,47) |
| Duration of illness (months), median(min-max) | 48 (3 – 300) |
| Treatment | |
| MTX, n (%) | 3 (8,57%) |
| MTX + steroid, n (%) | 32 (91,42%) |
| ESR | 42 (10 – 130) |
| DAS28ESR Score | |
| Median (min-max) | 4,21 (2,01-8,40) |
| Remission, n (%) | 2 (5,7) |
| Low, n (%) | 5 (14,3) |
| Moderate, n (%) | 23 (65,7) |
| High, n (%) | 5 (14,3) |